CellCentric's Seed VC - II Round

CellCentric raised a round of funding on April 19, 2005. Investors include UK Innovation & Science Seed Fund.

CellCentric is a clinical stage biotechnology company focused on the development of the novel drug CCS1477 for prostate (CRPC) and other cancers.…

Articles about CellCentric's Seed VC - II Round: